Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200065662Phase 4Not yet recruiting
Phase 4, randomised trial comparing Cyclopol group with Etomidate group (2 arms). Primary endpoints: Heart rate, Blood pressure and 1 more. Planned start Nov 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200065662.